Search Result "CRTH2 Agonists"
Prostaglandin D2 Receptors DP and CRTH2 in the Pathogenesis of Asthma
Journal: Current Molecular Medicine
Volume: 8 Issue: 5 Year: 2008 Page: 365-375
Author(s): Masafumi Arima, Takeshi Fukuda
Same Target, Different Therapeutic Outcomes: The Case of CAY10471 and Fevipiprant on CRTh2 Receptor in Treatment of Allergic Rhinitis and Asthma
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 22 Issue: 8 Year: 2019 Page: 521-533
Author(s): Abdul R. Issahaku,Clement Agoni,Opeyemi S. Soremekun,Patrick A. Kubi,Ransford O. Kumi,Fisayo A. Olotu,Mahmoud E.S. Soliman
Targeting the Prostaglandin D2 Receptors DP and CRTH2 for Treatment of Inflammation
Journal: Current Topics in Medicinal Chemistry
Volume: 6 Issue: 1 Year: 2006 Page: 1427-1444
Author(s): Trond Ulven, Evi Kostenis
Recent Progress in Work on PGD2 Antagonists for Drugs Targeting Allergic Diseases
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 2 Year: 2004 Page: 3533-3538
Author(s): Susumu Mitsumori
7-Azaindole Analogues as Bioactive Agents and Recent Results
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 9 Year: 2019 Page: 727-736
Author(s): Neha Sharma,Anurag
Drug Design of GPCR Ligands Using Physicogenetics and Chemogenomics - Principles and Case Studies
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1882-1901
Author(s): Thomas M. Frimurer, Thomas Hogberg
Role of Prostaglandins in Multiple Sclerosis
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 7 Year: 2020 Page: 730-742
Author(s): Surendra Gulla,Dakshayani Lomada,Anusha Lade,Reddanna Pallu,Madhava C. Reddy
Novel Insights into Biased Agonism at G Protein-Coupled Receptors and their Potential for Drug Design
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5156-5166
Author(s): Maria Marti-Solano, Ramon Guixa-Gonzalez, Ferran Sanz, Manuel Pastor, Jana Selent
Experimental Approaches Towards Allergic Asthma Therapy-Murine Asthma Models
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 4 Issue: 1 Year: 2010 Page: 37-53
Author(s): Michael Wegmann, Hans P. Hauber
The Interleukin-17/Interleukin-22 Innate Axis in the Gut as a New Drug Target in Allergic-Inflammatory and Autoimmune Diseases. A Working Hypothesis
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 14 Issue: 2 Year: 2014 Page: 145-151
Author(s): Thea Magrone,Emilio Jirillo